China Unveils Dongbi Index to Shift Focus Toward Research Quality in Journal Evaluation
Chinese researchers have introduced the Dongbi Index, a new methodology for evaluating medical and life science journals that moves beyond reliance on traditional journal impact factors. The lists were unveiled in Shanghai on March 21, 2026, covering 4,027 medical journals and 3,064 life science titles selected from more than 40,000 worldwide.
Developed by Shenzhen-based Dongbi Data in collaboration with the Institute of Medical Information & Library at the Chinese Academy of Medical Sciences, the system uses large-scale data analysis and a multidimensional evaluation framework centered on research quality rather than citation volume alone.
Traditional Journal Ranking Systems and Their Limitations
For decades, the journal impact factor has served as a primary metric for assessing academic journals. Calculated by Clarivate Analytics, it measures the average number of citations received by articles published in a journal over a specific period, typically two or five years. While widely used for hiring, promotion, and funding decisions, critics argue it overemphasizes quantity over quality and can be manipulated through practices like excessive self-citation or citation cartels.
Alternative systems such as the h-index for individual researchers or Eigenfactor scores attempt to address some shortcomings, but many academics seek more nuanced approaches that prioritize the substance of citations and the broader influence of published work.
China's Evolving Approach to Research Evaluation
China has long used journal rankings to guide academic incentives. The Chinese Academy of Sciences maintained a prominent classification table for over two decades until its discontinuation in 2026. This shift reflects broader policy efforts to reduce "journal centrism" and emphasize innovation, societal impact, and genuine research quality.
Against this backdrop, independent initiatives like the Dongbi Index have emerged to fill the gap and strengthen China's role in shaping global academic standards.
Launch Details and Development of the Dongbi Index
The Dongbi Index lists were presented at an event in Shanghai. Wu Dengsheng, founder of Dongbi Data and a professor at Shenzhen University’s College of Management, described the system as providing crucial support for moving beyond the dominance of impact factors and paper counts while enhancing China’s academic voice.
The project draws on data from 2023 to 2025 and combines proprietary algorithms with expert input from medical information specialists.
Photo by National Cancer Institute on Unsplash
Methodology: Citation Network Hierarchy and Quality Assessment
Unlike simple citation counts, the Dongbi Index evaluates the quality of citations by constructing citation networks. It operates on the principle that high-quality papers tend to cite work from similarly strong journals. Journals are then grouped into four tiers—A, B, C, and D—forming a pyramid structure based on this hierarchical analysis.
This "seed journal citation tracing and citation network hierarchy" approach aims to provide a more robust indicator of true scholarly influence across disciplines.
Scope of the Initial Dongbi Index Lists
The inaugural releases focus exclusively on medical and life sciences, two fields where Chinese researchers have made substantial contributions. Data indicate that Chinese authors accounted for nearly one-third of global academic papers in the life sciences during the analyzed period.
Future expansions are expected to cover additional disciplines, with early reports suggesting coverage of around 22,000 journals across 21 major fields in subsequent iterations.
Stakeholder Reactions and Expert Perspectives
Academic observers note that the Dongbi Index represents a private-sector innovation rather than a government mandate. University administrators and researchers in China are beginning to explore its potential integration into evaluation processes alongside existing metrics.
International commentators highlight its potential to diversify global journal assessment tools, though widespread adoption will depend on transparency of the underlying algorithms and independent validation studies.
Implications for Researchers, Institutions, and Publishing
For early-career academics, the new system could influence decisions about where to submit manuscripts, particularly in medical and life sciences. Institutions may incorporate Dongbi tiers into internal review frameworks for tenure and promotion.
Publishers are watching closely, as shifts in perceived prestige could affect submission volumes and citation patterns over time.
Challenges, Criticisms, and Opportunities for Refinement
Any new ranking system faces scrutiny regarding data sources, potential biases, and resistance from established players. Questions remain about how the Dongbi Index will handle emerging open-access models, preprint servers, and interdisciplinary work.
Proponents emphasize ongoing development and the value of multiple complementary evaluation tools rather than a single dominant metric.
Global Context and Future Outlook for Journal Evaluation
The introduction of the Dongbi Index occurs alongside other initiatives worldwide aimed at reforming research assessment. As China continues to expand its scholarly output, tools developed there are likely to gain international attention.
Academics interested in staying informed can monitor updates from Dongbi Data and related research bodies. For those navigating career decisions in higher education, resources on university positions and publishing strategies remain valuable.
